The herpes zoster vaccine (Zostavax) has been shown to greatly decrease the risk of shingles. The vaccine is approved by the Food and Drug Administration for adults age 50 and older and is recommended for all adults 60 and older who aren't allergic to the vaccine and who don't take immune-suppressing medications.

Sept. 16, 2015